Clinical Study
Recombinant Human Thrombopoietin Treatment Promotes Hematopoiesis Recovery in Patients with Severe Aplastic Anemia Receiving Immunosuppressive Therapy
Figure 1
Bone marrow megakaryocytes in patients treated with and without rhTPO at 3, 6, and 9 months (all ).